With the realization that half of the people experiencing a sudden mortal
heart attack were taking aspirin on the day of their demise, researchers have
begun to search for a more reliable alternative, and they may have found it
in a red wine molecule called resveratrol (rez-vair-ah-trawl).
Researchers at the University of Connecticut induced heart attacks in animals and found resveratrol significantly reduces damage to heart muscle. Scarring and fibrosis were limited and the animals survived an otherwise mortal event.
Resveratrol may provoke a pre-conditioning effect whereby antioxidant defenses in the heart are switched on prior to a heart attack, therefore limiting damage to heart muscle should such an event occur.
The dosage of resveratrol is critical in producing the pre-conditioning effect - researchers found the human equivalent dosage of 175-350 milligrams reduced damage to the heart during a heart attack, while ten times greater dose (1750-3500 mg) increased the area of damaged cardiac tissue.
A branded resveratrol pill, Longevinex(R) (www.longevinex.com) , was found to afford the same level of protection at a much lower dose - 100 milligrams of resveratrol, which may be due to its micronized, micronencapsulated delivery system and combination with other antioxidants (quercetin, rice bran, vitamin D and ferulic acid).
Since resveratrol also thins the blood and inhibits clots that form in coronary arteries in a similar fashion to aspirin, and exhibits other beneficial properties, such as anti-adhesion factors that inhibit plaque from sticking to artery walls, it may be superior to aspirin.
Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3
SOURCE Resveratrol Partners LLC
Advertisement
Researchers at the University of Connecticut induced heart attacks in animals and found resveratrol significantly reduces damage to heart muscle. Scarring and fibrosis were limited and the animals survived an otherwise mortal event.
Advertisement
Resveratrol may provoke a pre-conditioning effect whereby antioxidant defenses in the heart are switched on prior to a heart attack, therefore limiting damage to heart muscle should such an event occur.
The dosage of resveratrol is critical in producing the pre-conditioning effect - researchers found the human equivalent dosage of 175-350 milligrams reduced damage to the heart during a heart attack, while ten times greater dose (1750-3500 mg) increased the area of damaged cardiac tissue.
A branded resveratrol pill, Longevinex(R) (www.longevinex.com) , was found to afford the same level of protection at a much lower dose - 100 milligrams of resveratrol, which may be due to its micronized, micronencapsulated delivery system and combination with other antioxidants (quercetin, rice bran, vitamin D and ferulic acid).
Since resveratrol also thins the blood and inhibits clots that form in coronary arteries in a similar fashion to aspirin, and exhibits other beneficial properties, such as anti-adhesion factors that inhibit plaque from sticking to artery walls, it may be superior to aspirin.
SATELLITE FEEDS:
Thursday, February 25th, 2010 Friday, February 26th, 2010
3:00 PM - 3:15 PM ET 1:00 PM - 1:15 PM ET
Galaxy 19 AMC 3
C-Band C-Band
Transponder 8 Transponder 3
Downlink Freq. 3860 Horizontal Downlink Freq. 3760 Horizontal
NEWS: Could Resveratrol Replace Aspirin As A Heart Protector?
FORMAT: B-roll and Soundbites
ADDITIONAL RESOURCES: Video, contact information and more available at:
http://multivu.prnewswire.com/broadcast/42468/press.html
SOUNDBITES:
* Dipak K. Das, Ph.D., Professor/Director, The Cardiovascular Research
Center, University of Connecticut
B-ROLL INCLUDES:
* Various Lab Footage
* Red Wine
* Grapes
VIDEO PROVIDED BY: Resveratrol Partners LLCContact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3
SOURCE Resveratrol Partners LLC
